These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13105702)

  • 1. Studies on abnormal hemoglobins. VIII. The gelling phenomenon of sickle cell hemoglobin: its biologic and diagnostic significance.
    SINGER K; SINGER L
    Blood; 1953 Nov; 8(11):1008-23. PubMed ID: 13105702
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on abnormal hemoglobins. VI. Electrophoretic demonstration of type S (sickle cell) hemoglobin in erythrocytes incapable of showing the sickle cell phenomenon.
    SINGER K; FISHER B
    Blood; 1953 Mar; 8(3):270-5. PubMed ID: 13032196
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on abnormal hemoglobins. III. The interrelationship of type S (sickle cell) hemoglobin and type F (alkali resistant) hemoglobin in sickle cell anemia.
    SINGER K; CHERNOFF AI
    Blood; 1952 Jan; 7(1):47-52. PubMed ID: 14886409
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical manifestations of inherited abnormal hemoglobins. I. The interaction of hemoglobin-S with hemoglobin-D.
    STURGEON P; ITANO HA; BERGREN WR
    Blood; 1955 May; 10(5):389-404. PubMed ID: 14363320
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the destruction of red blood cells. VIII. Molecular orientation in sickle cell hemoglobin solutions.
    HARRIS JW
    Proc Soc Exp Biol Med; 1950 Oct; 75(1):197-201. PubMed ID: 14797780
    [No Abstract]   [Full Text] [Related]  

  • 6. INTRAERYTHROCYTIC HEMOGLOBIN CRYSTALS IN SICKLE CELL-HEMOGLOBIN C DISEASE.
    DIGGS LW; BELL A
    Blood; 1965 Feb; 25():218-23. PubMed ID: 14267697
    [No Abstract]   [Full Text] [Related]  

  • 7. Deoxyhemoglobin S: solubility vs. erythrocyte sickling.
    Vedvick TS; Koenig HM; Itano HA
    Clin Biochem; 1975 Aug; 8(4):288-90. PubMed ID: 1157297
    [No Abstract]   [Full Text] [Related]  

  • 8. THE FIRST OBSERVATION OF HOMOZYGOUS HEMOGLOBIN S-ALPHA THALASSEMIA DISEASE AND TWO TYPES OF SICKLE CELL THALASSEMIA DISEASE: (A) SICKLE CELL-ALPHA THALASSEMIA DISEASE, (B) SICKLE CELL-BETA THALASSEMIA DISEASE.
    AKSOY M
    Blood; 1963 Dec; 22():757-69. PubMed ID: 14084634
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on abnormal hemoglobins. XI. Sickle cell-thalassemia disease in the Negro; the significance of the S+A+F and S+A patterns obtained by hemoglobin analysis.
    SINGER K; SINGER L; GOLDBERG SR
    Blood; 1955 May; 10(5):405-15. PubMed ID: 14363321
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on abnormal hemoglobins. V. The distribution of type S, sickle cell, hemoglobin and type F, alkali resistant, hemoglobin within the red cell population in sickle cell anemia.
    SINGER K; FISHER B
    Blood; 1952 Dec; 7(12):1216-26. PubMed ID: 12997538
    [No Abstract]   [Full Text] [Related]  

  • 11. Further studies on hemoglobin C. II. The hematologic effects of hemoglobin C alone and in combination with sickle cell hemoglobin.
    KAPLAN E; ZUELZER WW; NEEL JV
    Blood; 1953 Aug; 8(8):735-46. PubMed ID: 13066515
    [No Abstract]   [Full Text] [Related]  

  • 12. Further studies on hemoglobin C. I. A description of three additional families segregating for hemoglobin C and sickle cell hemoglobin.
    NEEL JV; KAPLAN E; ZUELZER WW
    Blood; 1953 Aug; 8(8):724-34. PubMed ID: 13066514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the biological and physical-chemical properties of sickle-cell hemoglobin].
    BETKE K; GREINACHER I
    Klin Wochenschr; 1955 Jul; 33(25-26):611-2. PubMed ID: 13243611
    [No Abstract]   [Full Text] [Related]  

  • 14. Singer K, Fisher B. Studies on abnormal hemoglobins, VI: electrophoretic demonstration of type S (sickle cell) hemoglobin in erythrocytes incapable of showing the sickle cell phenomenon. Blood. 1953;8(3):270-275.
    Blood; 2016 Feb; 127(7):791. PubMed ID: 26893392
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyanate and sickle-cell disease.
    Cerami A; Peterson CM
    Sci Am; 1975 Apr; 232(4):44-50. PubMed ID: 1114310
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.
    SINGER K; CHERNOFF AI; SINGER L
    Blood; 1951 May; 6(5):413-28. PubMed ID: 14830637
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on the inheritance of sickle-cell hemoglobin and hemoglobin C.
    RANNEY HM
    J Clin Invest; 1954 Dec; 33(12):1634-41. PubMed ID: 13211820
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial differences in the proportion of abnormal hemoglobin present in the sickle cell trait.
    NEEL JV; WELLS IC; ITANO HA
    J Clin Invest; 1951 Oct; 30(10):1120-4. PubMed ID: 14888690
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Delay time of gelation: a possible determinant of clinical severity in sickle cell disease.
    Eaton WA; Hofrichter J; Ross PD
    Blood; 1976 Apr; 47(4):621-7. PubMed ID: 1260125
    [No Abstract]   [Full Text] [Related]  

  • 20. A new inherited abnormality of hemoglobin and its interaction with sickle cell hemoglobin.
    KAPLAN E; ZUELZER WW; NEEL JV
    Blood; 1951 Dec; 6(12):1240-9. PubMed ID: 14886398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.